The Superintelligence Observer
Weekly digest

Week of September 28, 2026

September 28, 2026 – October 4, 2026 · 36 stories

Google DeepMind announced Gemini 4 Argon, presented as a new era for its frontier models, while OpenAI recapped more than 20 DevDay announcements and released GPT-6.1 Sol at a fifth of Astra's API price. OpenAI also launched dots, proactive assistants for ongoing projects, and said it disrupted a coordinated campaign to distill its models' reasoning. On the infrastructure side, CoreWeave is bringing NVIDIA's next-generation hardware into production, and Amazon's $1 billion plan to address data center opposition drew criticism. In the U.S., a judge dismissed antitrust suits against Google's AI search, and authorities arrested a CEO accused of smuggling $300 million in Nvidia chips into China.

Model releases

OpenAI

Introducing GPT-6.1 Sol

OpenAI has released GPT-6.1 Sol, which it says comes close to Astra’s level on coding, computer use and professional work. Its API costs one-fifth of Astra’s standard price for input and output tokens.

Open source

Agents & harnesses

OpenAI

Are you a Codex Original?

OpenAI is collecting stories from developers, researchers and creators who use Codex for its Codex Originals program. Interested users can submit their project.

OpenAI

Introducing dots

OpenAI has launched dots, proactive assistants that keep working on complex projects and everyday tasks. The company says users stay in control while the work moves forward.

Frontier & AGI

OpenAI

The eternal complement

An OpenAI essay argues that advanced AI may have its biggest impact on the routine work that supports breakthrough ideas. It looks at how execution could shape the economy and the pace of progress.

Research

Products & apps

Chips & compute

Business & funding

Policy & regulation

Safety & security

Google DeepMind

Introducing SynthID Bio

Google DeepMind has presented SynthID Bio, a proof of concept for watermarking proteins designed by AI. The watermark is meant to leave the proteins’ biological function intact.